The $125 central target is calculated from four recent, attributable analyst targets, not a single website's headline consensus figure. JPMorgan's Sebastiano Petti holds an Overweight rating with a $130 target (trimmed from $133 in October 2026 after a sharp upward revision from $50 earlier in 2026). Clear Street's Greg Pendy initiated coverage at $161 in July 2026 and reiterated that level in August. Craig-Hallum carries a $121 target, while B. Riley—the most cautious—sits at $86 after downgrading the stock to Neutral in mid-2026. The four average to $124.50, rounded to $125, with a low-to-high range of $86 to $161.
That spread is unusually wide, and it reflects two competing narratives. Bulls such as Clear Street and JPMorgan emphasize a multi-billion-dollar utility modernization pipeline and argue the licensed spectrum is undervalued on a per-MHz-POP basis. The more cautious view, represented by B. Riley, highlights the uncertainty and timing involved in actually converting spectrum holdings into recurring, contracted revenue. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Notably, some third-party aggregators show lower averages—for example, a three-analyst figure near $112—because they include different subsets of analysts, which is why this analysis relies on the four individually verified targets.
Anterix Inc. (ATEX) last traded near $80.78, toward the middle of a 52-week range of roughly $17.82 to $113.00. Reaching $125 would require an upside of about 55%, which is a very large move by most standards and would also push the stock through its prior 52-week high near $113. The company recently reported a stronger-than-expected fiscal fourth quarter, including earnings per share (EPS) of about $0.98 versus a projected loss and revenue near $1.96 million against roughly $1.47 million expected. However, trailing revenue remains small—around $7 million—meaning the stock's valuation is anchored to the future value of its spectrum rather than current earnings power.
The core bull case rests on spectrum scarcity. Utilities are under pressure to replace aging analog networks as AI data centers, electric-vehicle (EV) electrification, and wildfire-hardening requirements strain the grid. Clear Street has cited a project pipeline it values at around $3 billion, and Anterix has signed new utility customers and spectrum agreements in recent quarters. The company also holds a strong balance sheet with roughly $116 million in cash and minimal debt, giving it flexibility to fund spectrum clearing. JPMorgan's sharp target increase reflects the view that the market still underappreciates the spectrum's value, and momentum in the shares—up more than 300% year-to-date at points in 2026—shows investor enthusiasm for the story. From what I see, monitoring these utility contracts remains key.
The principal risk is valuation. With a price-to-earnings (P/E) ratio in the low-to-mid 20s and a price-to-sales multiple far above peers, the stock prices in substantial future monetization that has not yet materialized. Independent discounted-cash-flow models have suggested the shares trade above intrinsic value, and revenue recognition is lumpy, making quarter-to-quarter results volatile. Spectrum clearing costs and execution timelines remain uncertain, and B. Riley's downgrade underscores concern that near-term upside may be limited. A broader rotation away from high-multiple small caps, or any disappointment in contract signings, could keep the stock well below $125.
Technically, the $113 level—the stock's 52-week high—represents the most important near-term resistance, since $125 sits above that prior peak. The psychologically significant $100 mark is an intermediate hurdle. On the downside, the $75–$81 zone has acted as recent support after the stock's pullback from its July 2026 highs, with the stock's dramatic 2026 run leaving thinner historical support below that.
Analyst price targets generally reflect a roughly 12-month research horizon, though firms do not always state this explicitly and individual assumptions vary. Investors should watch Anterix's quarterly earnings and guidance for signs that new spectrum agreements are converting into recognized revenue, along with any analyst target revisions in either direction. The company's fiscal 2027 report dates, new utility contract announcements, spectrum-clearing progress, and any news on satellite or direct-to-device trials (including work with Lynk Global) are the most relevant catalysts, alongside broader shifts in growth-stock sentiment and interest-rate expectations. I’m watching this closely for any shifts in contract momentum.
Can Anterix reach $125? The question turns less on near-term earnings than on whether the company can keep converting a scarce spectrum asset into contracted utility demand. The $125 target—the average of four analyst targets spanning $86 to $161—implies a roughly 55% gain and would require clearing the prior $113 high. Strong secular tailwinds in grid modernization and a clean balance sheet support the upside case, while a rich valuation, lumpy revenue, and monetization-timing uncertainty are the principal obstacles. The unusually wide analyst range signals that even professionals disagree sharply on fair value. Investors should monitor contract announcements, earnings, and analyst revisions rather than treat the $125 figure as a guaranteed destination.
AI Daily Buy/Sell Signals from Tickeron use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening. For those following Anterix or building a broader watchlist, these signals offer a systematic, data-driven complement to fundamental research and can be explored directly through Tickeron's platform. In my view, it provides a useful layer when evaluating names like this one amid volatile small-cap moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ATEX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 39 of 45 cases where ATEX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 87%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 57 cases where ATEX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
Following a +17.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATEX advanced for three days, in 181 of 249 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 143 of 192 cases where ATEX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ATEX as a result. In 68 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for ATEX turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 31 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
ATEX moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ATEX crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ATEX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.102) is normal, around the industry mean (2.292). P/E Ratio (21.185) is within average values for comparable stocks, (-7.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.005). Dividend Yield (0.000) settles around the average of (0.133) among similar stocks. ATEX's P/S Ratio (204.082) is very high in comparison to the industry average of (5.777).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a wireless communications company, which engages in the spectrum assets to enable targeted critical infrastructure and enterprise customers to deploy private broadband networks, technologies, and solutions.
Industry MajorTelecommunications